The estimated Net Worth of Michael S Aberman is at least $12.8 Million dollars as of 21 June 2017. Michael Aberman owns over 4,500 units of Regeneron Pharmaceuticals stock worth over $10,493,350 and over the last 15 years Michael sold REGN stock worth over $2,319,749.
Michael has made over 18 trades of the Regeneron Pharmaceuticals stock since 2011, according to the Form 4 filled with the SEC. Most recently Michael exercised 4,500 units of REGN stock worth $137,835 on 21 June 2017.
The largest trade Michael's ever made was exercising 12,500 units of Regeneron Pharmaceuticals stock on 13 May 2013 worth over $300,000. On average, Michael trades about 5,050 units every 85 days since 2010. As of 21 June 2017 Michael still owns at least 9,193 units of Regeneron Pharmaceuticals stock.
You can see the complete history of Michael Aberman stock trades at the bottom of the page.
Over the last 22 years, insiders at Regeneron Pharmaceuticals have traded over $13,084,686,326 worth of Regeneron Pharmaceuticals stock and bought 8,562,481 units worth $2,539,854,760 . The most active insiders traders include Sanofi, Pharma Ag Novartis, and Leonard S Schleifer. On average, Regeneron Pharmaceuticals executives and independent directors trade stock every 8 days with the average trade being worth of $47,694,347. The most recent stock trade was executed by Marion Mc Court on 3 September 2024, trading 1,000 units of REGN stock currently worth $381,400.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Regeneron Pharmaceuticals executives and other stock owners filed with the SEC include: